arrow
返回
刘明耀 封面图

刘明耀 (Mingyao Liu)

hainan medical university

84H指数
609论文数
2.5W被引数
收录论文 311
发表时间
Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy发现和表征苯甲酰胺衍生物作为癌症免疫疗法中高活性SUCNR1拮抗剂
err2026-05-08
err0
PREAI
errZhiyuan Cheng; Jiacheng He; Changyao Li; Ke Quan; Limin Du; Xiaolei Chai; Xinyu Yang; Naijipu Abuduaini; Yuanyuan Fu; Jing Sun; Sen Zhang; Bo Feng; Deyan Wu; Weiwei Rui; H. Eric Xu; Linlin Yang; Mingyao Liu; Weiqiang Lu
err分享
err收藏
Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression作者更正:PPIA决定NRF2的稳定性以促进肺癌进展
err2025-12-15
err0
errOAAI
errWeiqiang Lu; Jiayan Cui; Wanyan Wang; Qian Hu; Yun Xue; Xi Liu; Ting Gong; Yiping Lu; Hui Ma; Xinyu Yang; Bo Feng; Qi Wang; Naixia Zhang; Yechun Xu; Mingyao Liu; Ruth Nussinov; Feixiong Cheng; Hongbin Ji; Jin Huang
err分享
err收藏
Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis外源性激活粘附G蛋白偶联受体ADGRD1/GPR133通过负向调控破骨细胞生成来保护骨量免于流失。
err2025-07-11
err0
errOAAI
errLiang He; Qiansen Zhang; Yu You; Peng Sun; Ziwei Xu; Rong Li; Fanhua Wang; Shaoying Zhang; Jiangnan He; Juwen Shen; Lei Zhao; Yang Hong; Yinghua Li; Mingyao Liu; Jin-peng Sun; Ning Wang; Yeqing Sun; Huaiyu Yang; Jian Luo
err分享
err收藏
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission同种异体CD19靶向CAR-T疗法在难治性系统性红斑狼疮中实现了持久的缓解
errMed
IF11.8
err2025-05-29
err0
PREAI
errDandan Wang; Xiaobing Wang; Binghe Tan; Xin Wen; Songying Ye; Yingyi Wu; Xuan Cao; Xin Zhang; Chun Wang; Linyu Geng; Huayong Zhang; Xuebing Feng; Biao Zheng; Yanran He; Mingyao Liu; Xin Wu; Bing Du; Lingyun Sun; Huji Xu
err分享
err收藏
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus异基因抗CD19 CAR-T细胞可诱导难治性系统性红斑狼疮缓解
err2025-05-08
err0
errOAAI
errChunmei Yang; Chuanyin Sun; Binghe Tan; Chao Hu; Liyan Wan; Chris Wang; Xiujuan Shi; Juliang Qin; Na Zhang; Biao Zheng; Mingyao Liu; Jin Lin; Bing Du; Hongyan Tong
err分享
err收藏
Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma选择性使用小分子抑制剂靶向BCL6是胶质母细胞瘤的一种潜在治疗策略
err2025-04-15
err0
errOAAI
errMin Wu; Lin Zhang; Weikai Guo; Shiyi Lv; Wangrui Jin; Shuangshuang Zhu; Huang Chen; Shuyi Jian; Layang Liu; Yajing Xing; Shihong Peng; Mingyao Liu; Yihua Chen; Zhengfang Yi
err分享
err收藏
Design, synthesis and biological evaluation of bisnoralcohol derivatives as novel IRF4 inhibitors for the treatment of multiple myeloma
err2025-03-01
err0
PREAI
errZhang, Jing-Zan; Zhang, Lin; Ding, Xin; Wu, Min; Zhang, De-Jie; Wu, Yujie; Liu, Mingyao; Li, Chen-Chen; Yi, Zhengfang; Qiu, Wen-Wei
err分享
err收藏
Design, synthesis, and biological evaluations of 5-aryl-pyrazole-3-carboxamide derivatives as selective CB2 receptor agonists for the treatment of colitis
err2025-02-01
err0
PREAI
errJiang, Bei-Er; He, Ying; Chen, Jie; Jiang, Xing-Wu; Qiu, Zi-Liang; Liang, Qiu-Wen; Gao, Xin-Long; Zhang, Han-Kun; Tian, Hai-Gang; Liu, Ming-Yao; Lu, Wei-Qiang; Yu, Li-Fang
err分享
err收藏
Subtle Structural Modifications Spanning from EP4 Antagonism to EP2/EP4 Dual Antagonism: A Novel Class of Thienocyclic-Based Derivatives从EP4拮抗到EP2/EP4双重拮抗的微妙结构修饰:一类新型的噻吩环基衍生物
err2025-01-06
err1
PREAI
errCheng, Zhiyuan; Zhang, Yao; Du, Limin; Wang, Wei; Chai, Xiaolei; He, Mengxian; Zhang, Hankun; Wu, Deyan; Lu, Jian; Zhang, Sen; Feng, Bo; Yang, Linlin; Liu, Mingyao
err分享
err收藏
Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src (vol 15, 1300, 2024)
err2024-12-19
err0
errOAAI
errLi, Zhenxi; Yang, Xinghai; Fu, Ruifeng; Wu, Zhipeng; Xu, Shengzhao; Jiao, Jian; Qian, Ming; Zhang, Long; Wu, Chunbiao; Xie, Tianying; Yao, Jiqiang; Wu, Zhixiang; Li, Wenjun; Ma, Guoli; You, Yu; Chen, Yihua; Zhang, Han-kun; Cheng, Yiyun; Tang, Xiaolong; Wu, Pengfei; Lian, Gewei; Wei, Haifeng; Zhao, Jian; Xu, Jianrong; Ai, Lianzhong; Siwko, Stefan; Wang, Yue; Ding, Jin; Song, Gaojie; Luo, Jian; Liu, Mingyao; Xiao, Jianru
err分享
err收藏
IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway
err2024-11-20
err0
PREAI
errLv, Shiyi; Zhang, Lin; Wu, Min; Zhu, Shuangshuang; Wang, Yixue; Liu, Layang; Li, Yunxuan; Zhang, Ting; Wu, Yujie; Chen, Huang; Liu, Mingyao; Yi, Zhengfang
err分享
err收藏
A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma一种小分子BCL6抑制剂作为弥漫性大b细胞淋巴瘤的抗增殖剂
err2024-10-10
err0
PREAI
errXing, Yajing; Guo, Weikai; Wu, Min; Xie, Jiuqing; Huang, Dongxia; Hu, Pan; Zhou, Miaoran; Zhang, Lin; Zhong, Yadong; Liu, Mingyao; Chen, Yihua; Yi, Zhengfang
err分享
err收藏
Corrigendum to 'JD-312 - A novel small molecule that facilitates cartilage repair and alleviates osteoarthritis progression'[Journal ' [Journal of Orthopaedic Translation 44 (2024) 60-71] - 71]
err2024-09-01
err0
errOAAI
errGao, Jingduo; Pei, Haixiang; Lv, Fang; Niu, Xin; You, Yu; He, Liang; Hu, Shijia; Shah, Karan M.; Liu, Mingyao; Chen, Yihua; Du, Bing; Xiong, Hai; Luo, Jian
err分享
err收藏
Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos
err2024-08-01
err2
PREAI
errXue, Niannian; Hong, Dishan; Zhang, Dan; Wang, Qian; Zhang, Shun; Yang, Lei; Chen, Xi; Li, Yongmei; Han, Honghui; Hu, Chunyi; Liu, Mingyao; Song, Gaojie; Guan, Yuting; Wang, Liren; Zhu, Yifan; Li, Dali
err分享
err收藏
Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4
err2024-07-01
err0
errOAAI
errGuo, Mengmeng; Hu, Pan; Xie, Jiayi; Tang, Kefu; Hu, Shixiu; Sun, Jialiang; He, Yundong; Li, Jing; Lu, Weiqiang; Liu, Huirong; Liu, Mingyao; Yi, Zhengfang; Peng, Shihong
err分享
err收藏
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression (vol 40, pg 1440, 2021)
err2024-06-05
err0
errOAAI
errChen, Huang; Bian, Aiwu; Yang, Lian-fang; Yin, Xuan; Wang, Jie; Ti, Chaowen; Miao, Ying; Peng, Shihong; Xu, Shifen; Liu, Mingyao; Qiu, Wen-Wei; Yi, Zhengfang
err分享
err收藏
PPIA dictates NRF2 stability to promote lung cancer progressionPPIA决定NRF2稳定性以促进肺癌进展
err2024-06-03
err3
errOAAI
errLu, Weiqiang; Cui, Jiayan; Wang, Wanyan; Hu, Qian; Xue, Yun; Liu, Xi; Gong, Ting; Lu, Yiping; Ma, Hui; Yang, Xinyu; Feng, Bo; Wang, Qi; Zhang, Naixia; Xu, Yechun; Liu, Mingyao; Nussinov, Ruth; Cheng, Feixiong; Ji, Hongbin; Huang, Jin
err分享
err收藏

研究方向

基因编辑技术与细胞治疗产品的基础研究与临床转化乳酸受体HCAR1驱动免疫抑制PMN-MDSCs招募26(3):391-403.187(18):4890-4904.e9.非病毒特异性靶向CAR-T细胞在B-NHL中的安全性与高效性609(7926):369-374.CRISPR-Cas9基因编辑治疗β地中海贫血28(8):1573-1580.靶向蛋白降解5(1):129.深海真菌次级代谢产物抗骨质疏松活性30(3):276-278.基于E3连接酶DCAF15的PROTACs诱导的靶蛋白降解骨吸收与破骨细胞分化调控机制研究22(5):539-46.小分子靶向myoferlin乳腺癌抗肿瘤9(1):3726.KRas突变癌症抑制KRAS、PLK1与ROCK联合抑制β地中海贫血基因治疗调控生物学在体基因编辑及示踪新技术研发新型基因定点敲入和敲除技术开发孤儿G-蛋白偶联受体功能与信号通路配体发现LGR受体家族调控前列腺肿瘤干细胞前列腺癌发生发展分子机制基于GPCR结构与功能的新药创制孤儿GPCR在发育和正常生理功能中的作用G蛋白偶联受体及其信号传导在乳腺发育及乳腺癌中的作用